# Hologic to acquire Mobidiag for $795M

Hologic has entered a definitive agreement to acquire Finnish-French molecular diagnostic test developer Mobidiag for an enterprise value of approximately $795 million, including $714 million in cash for equity and $81 million in net debt.

- Type: Acquisition
- Announced: 2021-04-09
- Value: $795.0M
- Status: announced
- Products: molecular diagnostic tests, PCR-based tests, Amplidiag platform, Novodiag platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hologic](https://endata.com/companies/22178.md) (acquirer)
- [Mobidiag](https://endata.com/companies/36258.md) (target)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/hologic-acquire-mobidiag-795m/), 2021-04-09: "Hologic has entered a definitive agreement to acquire Finnish-French molecular diagnostic test developer Mobidiag for an enterprise value of approximately $795m."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.